Serum potential biomarkers according to sputum inflammatory cell profiles in adult asthmatics
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Background/Aims: Asthma is not a single disease but, rather, a heterogeneous inf lammatory disorder with various pathogenic mechanisms. We analyzed the associations between the cellular profile of sputum and the serum levels of inflammatory mediators/cytokines in a cohort of adult asthmatics. Methods: We recruited 421 adult asthmatic patients. All subjects were classified into four groups according to their sputum cellular profiles: G1, eosinophilic; G2, mixed granulocytic; G3, neutrophilic; and G4, paucigranulocytic. Serum levels of cytokines and mediators including periostin, eosinophil-derived neurotoxin (EDN), S100A9, and folliculin were quantified. Results: Among 421 patients, G1 accounted for 149 (35.4%), G2 for 71 (16.9%), G3 for 155 (36.8%), and G4 for 46 (10.9%). Serum periostin and EDN levels were significantly higher in G1 (p = 0.004, and p = 0.031) than in the others. Serum S100A9 levels were elevated in G2 and G3 (p = 0.008). Serum folliculin levels differed significantly among the four groups, with the highest level in G4 (p = 0.042). To identify G1 from G1 plus G2 groups, the optimal serum cut-off levels were 1.71 ng/mL for periostin, and 1.61 ng/mL for EDN. When these two parameters were combined, the sensitivity was 76.0% and the specificity was 64.3% (area under the curve, 0.701; p = 0.004). Conclusions: The serum periostin and EDN levels may be used as predictors to discriminate the eosinophilic asthma group from patients having eosinophilic or mixed granulocytic asthma, and the serum folliculin level is significantly elevated in patients with paucigranulocytic asthma compared to those with different inflammatory cell profile.
Abstract
Background/Aims: Asthma is not a single disease but, rather, a heterogeneous inf lammatory disorder with various pathogenic mechanisms. We analyzed the associations between the cellular profile of sputum and the serum levels of inflammatory mediators/cytokines in a cohort of adult asthmatics. Methods: We recruited 421 adult asthmatic patients. All subjects were classified into four groups according to their sputum cellular profiles: G1, eosinophilic; G2, mixed granulocytic; G3, neutrophilic; and G4, paucigranulocytic. Serum levels of cytokines and mediators including periostin, eosinophil-derived neurotoxin (EDN), S100A9, and folliculin were quantified. Results: Among 421 patients, G1 accounted for 149 (35.4%), G2 for 71 (16.9%), G3 for 155 (36.8%), and G4 for 46 (10.9%). Serum periostin and EDN levels were significantly higher in G1 (p = 0.004, and p = 0.031) than in the others. Serum S100A9 levels were elevated in G2 and G3 (p = 0.008). Serum folliculin levels differed significantly among the four groups, with the highest level in G4 (p = 0.042). To identify G1 from G1 plus G2 groups, the optimal serum cut-off levels were 1.71 ng/mL for periostin, and 1.61 ng/mL for EDN. When these two parameters were combined, the sensitivity was 76.0% and the specificity was 64.3% (area under the curve, 0.701; p = 0.004). Conclusions: The serum periostin and EDN levels may be used as predictors to discriminate the eosinophilic asthma group from patients having eosinophilic or mixed granulocytic asthma, and the serum folliculin level is significantly elevated in patients with paucigranulocytic asthma compared to those with different inflammatory cell profile.
참고문헌 (40)
- Moore WC, "Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program", Am J Respir Crit Care Med, 181, pp.315~323 (2010)
- Katial RK, "Changing paradigms in the treatment of severe asthma : the role of biologic therapies", J Allergy Clin Immunol Pract, 5, pp.S1~S14 (2017)
- Wang YH, "A novel subset of CD4(+)T(H)2 memory", effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma, 2010, pp.207, 2479~2491
- Irvin C, "Increased frequency of dual-positive TH2", TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma, 2014, pp.134, 1175~1186
- Liu W, "Mechanism of T(H)2", T(H)17-predominant and neutrophilic T(H)2, J Allergy Clin Immunol, pp.2017, 139[DOI]
- Kim MA, "Adult asthma biomarkers", Curr Opin Allergy Clin Immunol, 14, pp.49~54 (2014)
- Hastie AT, "Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes", J Allergy Clin Immunol, 125, pp.1028~1036 (2010)
- Halayko AJ, "S100A8", A9 : a mediator of severe asthma pathogenesis and morbidity, 2009, pp.87, 743~755
- pham le duy, "Epithelial folliculin is involved in airway inflammation in workers exposed to toluene diisocyanate", Experimental and Molecular Medicine, 49, pp.1~6 (2017), 생화학분자생물학회
- Davies AR, "Induced sputum in asthma : diagnostic and therapeutic implications", Curr Opin Pulm Med, 19, pp.60~65 (2013)
- Katz LE, "Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma", Ann Am Thorac Soc, 11, pp.531~536 (2014)
- Ullmann N, "Blood eosinophil counts rarely reflect airway eosinophilia in children with severe asthma", Allergy, 68, pp.402~406 (2013)
- 이영수, "Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics", Allergy, Asthma & Immunology Research, 11(3), pp.394~405 (2019), 대한천식알레르기학회
- "GINA report, global strategy for asthma management and prevention" (2019)[URL]
- Chung KF, "International ERS", ATS guidelines on definition, evaluation and treatment of severe asthma, 2014, pp.43, 343~373
- Gibson PG, "Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood", Am J Respir Crit Care Med, 158, pp.36~41 (1998)
- Brooks CR, "Relationship between airway neutrophilia and ageing in asthmatics and non-asthmatics", Respirology, 18, pp.857~865 (2013)
- Simpson JL, "Inflammatory subtypes in asthma : assessment and identification using induced sputum", Respirology, 11, pp.54~61 (2006)
- ten Brinke A, "Refractory eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids", Am J Respir Crit Care Med, 170, pp.601~605 (2004)
- Tliba O, "Paucigranulocytic asthma : uncoupling of airway obstruction from inflammation", J Allergy Clin Immunol, 143, pp.1287~1294 (2019)
- Taylor SL, "Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology", J Allergy Clin Immunol, 141, pp.94~103 (2018)
- Gibson PG, "Inflammatory phenotypes in adult asthma : clinical applications", Clin Respir J, 3, pp.198~206 (2009)
- Shin B, "The transition of sputum inflammatory cell profiles is variable in stable asthma patients", Asia Pac Allergy, 7, pp.19~28 (2017)
- Ntontsi P, "Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma : comparison with different sputum phenotypes", Allergy, 72, pp.1761~1767 (2017)
- Louis R, "The relationship between airways inflammation and asthma severity", Am J Respir Crit Care Med, 161, pp.9~16 (2000)
- Morioka J, "Concentrations of eosinophil-derived neurotoxin in the blood and urine of patients with allergic diseases", Allergol Int, 53, pp.359~367 (2004)
- Kim KW, "Serum eosinophil-derived neurotoxin(EDN)in diagnosis and evaluation of severity and bronchial hyperresponsiveness in childhood asthma", Lung, 185, pp.97~103 (2007)
- 이용주, "Biomarkers for Recurrent Wheezing and Asthma in Preschool Children", Allergy, Asthma & Immunology Research, 11(1), pp.16~28 (2019), 대한천식알레르기학회
- Pham TH, "Reductions in eosinophil biomarkers by benralizumab in patients with asthma", Respir Med, 111, pp.21~29 (2016)
- Takayama G, "Periostin : a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals", J Allergy Clin Immunol, 118, pp.98~104 (2006)
- Semprini R, "Type 2 biomarkers and prediction of future exacerbations and lung function decline in adult asthma", J Allergy Clin Immunol Pract, 6, pp.1982~1988 (2018)
- O’Dwyer DN, "The role of periostin in lung fibrosis and airway remodeling", Cell Mol Life Sci, 74, pp.4305~4314 (2017)
- Jia G, "Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients", J Allergy Clin Immunol, 130, pp.647~654 (2012)
- Henke MO, "Up-regulation of S100A8 and S100A9 protein in bronchial epithelial cells by lipopolysaccharide", Exp Lung Res, 32, pp.331~347 (2006)
- Ryckman C, "Proinflammatory activities of S100 : proteins S100A8, S100A9, and S100A8", A9 induce neutrophil chemotaxis and adhesion, 2003, pp.170, 3233~3242
- Khabibullin D, "Folliculin regulates cell-cell adhesion, AMPK, and mTORC1 in a cell-type-specific manner in lung-derived cells", Physiol Rep, 2, pp.e12107~ (2014)
- Trinh HKT, "Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease", Clin Exp Allergy, 48, pp.1464~1473 (2018)
- Simpson JL, "Assessment and reproducibility of non-eosinophilic asthma using induced sputum", Respiration, 79, pp.147~151 (2010)
- Hargreave FE, "Point : is measuring sputum eosinophils useful in the management of severe asthma? Yes", Chest, 139, pp.1270~1273 (2011)
- D’silva L, "Changing pattern of sputum cell counts during successive exacerbations of airway disease", Respir Med, 101, pp.2217~2220 (2007)